| 12/2/2024 | BK | Market Commentary: Dechra updated; Culligan, Vistra, BrightSpring, CQP, Innio, Starwood and many more set talk
|
| 4/1/2021 | CLHY | Market Commentary: Ingram, WW, Aegion, Cologix, AIT, Magnite, Adient, Aramark, Ufinet and more break
|
| 5/21/2012 | PP | Radient Pharmaceuticals gets forbearance on preferreds, notes defaults
|
| 4/3/2012 | PP | Radient Pharmaceuticals gets more default notices on preferreds, notes
|
| 3/28/2012 | PP | Radient Pharmaceuticals defaults on preferreds, $4.98 million of notes
|
| 2/23/2012 | PP | Radient Pharmaceuticals sells $3.32 million of discounted convertibles
|
| 11/29/2011 | PP | Radient once more revises $4.95 million of convertibles and preferreds
|
| 8/29/2011 | PP | Radient again amends terms of $4.95 million convertibles, preferreds
|
| 8/2/2011 | PP | Radient Pharmaceuticals amends terms of $4.95 million of convertibles
|
| 7/25/2011 | PP | Radient may be in default, after settling disagreement with investors
|
| 7/1/2011 | PP | Radient Pharmaceuticals settles default, disagreement with investors
|
| 6/2/2011 | PP | Radient Pharmaceuticals receives default notices from two noteholders
|
| 5/11/2011 | PP | Radient defaults on convertible notes, looks for 'amicable solution'
|
| 1/31/2011 | PP | Radient Pharmaceuticals plans $8.4 million convertible notes placement
|
| 1/24/2011 | PP | Radient Pharmaceuticals swaps convertible promissory notes for shares
|
| 10/15/2010 | PP | Radient Pharmaceuticals gets default waiver for 12% convertible notes
|
| 4/13/2010 | PP | New Issue: Radient Pharmaceuticals seals $5.52 million convertible notes placement
|
| 11/30/2009 | PP | New Issue: Radient prices $1 million direct placement of shares and warrants
|
